These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5848052)

  • 1. Inhibition of uric acid biosynthesis in the chick embryo and chicken by a xanthine oxidase inhibitor, 4-hydroxypyrazolo(3,4d)pyrimidine.
    Krakoff IH; Meyer RL
    J Pharmacol Exp Ther; 1965 Sep; 149(3):417-22. PubMed ID: 5848052
    [No Abstract]   [Full Text] [Related]  

  • 2. Purine metabolism in the chick embryo; effects of uricogenesis and xanthine oxidase inhibition.
    Duggan DE; Pua KH; Elfenbein G
    Mol Pharmacol; 1968 Jan; 4(1):53-60. PubMed ID: 5640779
    [No Abstract]   [Full Text] [Related]  

  • 3. [Regulation of synthesis of uric acid as the final stage of nitrogen metabolism].
    Matsuda Y
    Saishin Igaku; 1972 Apr; 27(4):798-805. PubMed ID: 4402597
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of xanthine oxidase by synthetic cytokinin analogues.
    Sheu SY; Lin YC; Chiang HC
    Anticancer Res; 1997; 17(2A):1043-9. PubMed ID: 9137447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric acid production with particular reference to the role of xanthine oxidase and its inhibition.
    Watts RW
    Proc R Soc Med; 1966 Apr; 59(4):287-92. PubMed ID: 5937675
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of some therapeutic agents on the biosynthesis of uric acid].
    Ramia J; Bozal J; Calvet F
    Rev Esp Fisiol; 1966 Sep; 22(3):85-97. PubMed ID: 5995778
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of colchicine and allopurinol on uricogenesis. II. Effect of administration to chicks and mice].
    Escarmís C; Bozal J; Calvet F
    Rev Esp Fisiol; 1970 Jun; 26(2):121-9. PubMed ID: 5511286
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic control of enzyme structure in hyperuricemia.
    Inwang EE
    Comp Biochem Physiol B; 1971 Jul; 39(3):569-77. PubMed ID: 4330727
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of nitroimidazole and nitrofuran derivatives on uric acid formation in an anaerobic environment by xanthine oxidase and microsomal nitroreductase].
    Derache P; Massol M; Derache R
    Ann Pharm Fr; 1983; 41(3):261-8. PubMed ID: 6689261
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the formation of uric acid by hepatic xanthinedehydrogenase].
    Domingo E; Bozal J; Calvet F
    Rev Esp Fisiol; 1967 Sep; 23(3):145-54. PubMed ID: 5614794
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of substrates on gene-controlled enzyme activities in cultured embryonic cells of Drosophila.
    Horikawa M; Ling LN; Fox AS
    Genetics; 1967 Mar; 55(3):569-83. PubMed ID: 6038425
    [No Abstract]   [Full Text] [Related]  

  • 12. Biosynthesis of uric acid in the tunicate, Molgula manhattensis, with a general scheme for the function of stored purines in animals.
    Nolfi JR
    Comp Biochem Physiol; 1970 Aug; 35(4):827-42. PubMed ID: 4916384
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of 4-hydroxypyrazolo(3,4-d)pyrimidine upon the catabolism of purines by various tissues of the rat and upon the rate of growth of Morris 5123-C hepatoma.
    Alexander JA; Wheeler GP; Hill DD; Morris HP
    Biochem Pharmacol; 1966 Jul; 15(7):881-9. PubMed ID: 4290921
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of gout.
    Lampe WT
    Pa Med; 1967 Jan; 70(1):52-3. PubMed ID: 6037719
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenocopies of the ma-1 and ry mutants of Drosophila melanogaster: inhibition in vivo of xanthine dehydrogenase by 4-hydroxypyrazolo(3,4-d)pyrimidine.
    Keller EC; Glassman E
    Nature; 1965 Oct; 208(5006):202-3. PubMed ID: 5884262
    [No Abstract]   [Full Text] [Related]  

  • 16. [Congenital hyperuricemia with neurologic disorders].
    Berger R; Broyer M
    Presse Med (1893); 1968 Jun; 76(27):1337-8. PubMed ID: 5725371
    [No Abstract]   [Full Text] [Related]  

  • 17. Irreversible enzyme inhibitors. XCV. 8-(m-bromoacetamidobenzylthio)hypoxanthine, an active-site-directed irreversible inhibitor of xanthine oxidase.
    Baker BR; Kozma J
    J Med Chem; 1967 Jul; 10(4):682-5. PubMed ID: 6068312
    [No Abstract]   [Full Text] [Related]  

  • 18. Xanthine oxidase inhibition in the management of hyperuricemia in leukemias and lymphomas.
    Krakoff IH
    Arthritis Rheum; 1965 Oct; 8(5):897-8. PubMed ID: 5859560
    [No Abstract]   [Full Text] [Related]  

  • 19. Xanthine oxidase activity in human tissues and its inhibition by allopurinol (4-hydroxypyrazolo[3,4-d] pyrimidine).
    Watts RW; Watts JE; Seegmiller JE
    J Lab Clin Med; 1965 Oct; 66(4):688-97. PubMed ID: 5843095
    [No Abstract]   [Full Text] [Related]  

  • 20. Xanthine oxidase (XO): relative configuration of complexes formed by the enzyme, 2- or 8-n-alkyl-hypoxanthines and 2-n-alkyl-8-azahypoxanthines. XII.
    Biagi G; Giorgi I; Livi O; Scartoni V; Tonetti I; Lucacchini A
    Farmaco; 1993 Mar; 48(3):357-74. PubMed ID: 8323669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.